Score mapped
Interactive worksheet
Clinical inputs
0/2 filled
Clinical contextWhy this tool matters and how to interpret it
Understand the result,
not just the number.
National Amyloidosis Centre (NAC) Risk Score: Explanation and Clinical Context The NAC staging system stratifies patients with transthyretin cardiac amyloidosis (ATTR-CA) into prognostic categories based on NT-proBNP and eGFR levels. Stage 1 indicates a lower risk of mortality, while Stage 3 denotes a higher risk. This system aids clinicians in assessing disease severity and guiding treatment decisions.
Evidence & references1 primary source mapped
- Source 1
Nitsche C, et al. Expansion of the National Amyloidosis Centre staging system to detect early mortality risk in transthyretin cardiac amyloidosis. Eur J Heart Fail. 2024;26(7):1234-1242. doi:10.1002/ejhf.2997
Clinical discussionModerated, tool-specific conversation
Loading discussion…